3D Bioprinting Market Size to Exceed $5.11 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the 3D Bioprinting Market Grown from 2024 to 2025?
The expansion of the 3D bioprinting market has been swift in the past few years. Its size is projected to surge from $1.86 billion in 2024 up to $2.21 billion in 2025, equating to a compound annual growth rate (CAGR) of 19.1%. This substantial growth during the previous period stems from factors such as investment in research and development, the upsurge in chronic diseases, scarcity of organs, increase in drug testing, and advancements in tissue engineering.
What Growth Rate Is Anticipated for the 3D Bioprinting Market in the Coming Years?
The market size of 3D bioprinting is projected to enjoy exponential expansion in the coming years, estimated to hit a value of $5.11 billion by 2029, rising at a compound annual growth rate (CAGR) of 23.3%. This predicted surge during the forecast period can be credited to improvements in healthcare, emerging development in bioprinted skin, increased patient awareness, and an aging population. Noteworthy trends anticipated during this forecast period are multi-material printing, vascularization methods, organ-on-a-chip, tailored implants, and biofabrication in space.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5341&type=smp
Who Are the Leading Companies in the 3D Bioprinting Market?
Major companies operating in the 3D bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.
What Are the Key Drivers of the 3D Bioprinting Market?
The growth of the 3D bioprinting market is anticipated to be propelled by escalating governmental and private investment in 3D bioprinting research activities during the forecast timeframe. The surge in 3D bioprinting applications in the healthcare sector has piqued the interest of private and governmental organizations, thus leading to funding. Such funding renders both financial and technical aid throughout various stages of 3D bioprinting technique development. For example, the European Union granted Readily3D SA, a bioprinting firm based in Switzerland, a fund worth $600,000 in May 2022, for creating a live miniature pancreas model employing its Tomolite 3D bioprinting technology. Similarly, the Australian Health Minister bestowed Curtin University with $737,690 in funds, enabling it to develop and enhance 3D bioprinting technology for directly depositing skin tissues onto model wounds, laying the groundwork for future human skin regeneration.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=5341&type=smp
What Are the Key Market Segments in the 3D Bioprinting Industry?
The 3D bioprinting market covered in this report is segmented –
1) By Component: 3D Bioprinters, Bioinks
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Other Materials
3) By Application: Research Applications, Clinical Application, Other Applications
4) By End User: Research Organization And Academic Institutes, Biopharmaceuticals Companies, Hospitals, Other End Users
Subsegments:
1) By 3D Bioprinters: Inkjet 3D Bioprinters, Microextrusion 3D Bioprinters, Laser-Assisted 3D Bioprinters, Stereolithography (SLA) Bioprinters
2) By Bioinks: Natural Bioinks, Synthetic Bioinks, Hybrid Bioinks, Hydrogels
What Are the Latest Trends in the 3D Bioprinting Market?
In the 3D bioprinting market, key players are emphasizing the advancement of next-gen bioprinters designed for use in tissue engineering and regenerative medicine. These specialized machines, known as bio 3D printers, fabricate biologically compatible structures like tissues and organs from bioinks, which are crafted from living cells or biocompatible substances. For example, in November 2022, Avay Biosciences, a healthcare firm from India, introduced the Mito Plus. This particular printer provides solutions to significant issues such as organ scarcity and enhances drug testing methods by facilitating intricate human tissue creation. The Mito Plus boasts several standout features including fine-tuned temperature control (4°C to 80°C), a dual-extruder system for multi-biomaterial use, built-in UV curing for better tissue quality, and HEPA filters ensuring a sterile printing ambiance.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/3d-bioprinting-global-market-report
What Are the Key Regional Markets in the 3D Bioprinting Industry?
North America was the largest region in the 3D bioprinting market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5341
This Report Delivers Insight On:
1. How big is the 3d bioprinting market, and how is it changing globally?
2. Who are the major companies in the 3d bioprinting market, and how are they performing?
3. What are the key opportunities and risks in the 3d bioprinting market right now?
4. Which products or customer segments are growing the most in the 3d bioprinting market?
5. What factors are helping or slowing down the growth of the 3d bioprinting market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
